Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Sook-Bin Woo, D.M.D., B.D.S.

Co-Author

This page shows the publications co-authored by Sook-Bin Woo and Nathaniel Treister.
Connection Strength

6.667
  1. Topical n-docosanol for management of recurrent herpes labialis. Expert Opin Pharmacother. 2010 Apr; 11(5):853-60.
    View in: PubMed
    Score: 0.433
  2. Use of cone-beam computerized tomography for evaluation of bisphosphonate-associated osteonecrosis of the jaws. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010 May; 109(5):753-64.
    View in: PubMed
    Score: 0.433
  3. Comments on "Osteonecrosis of the jaws in intravenous bisphosphonate use: proposal for a modification of the clinical classification". Oral Oncol. 2009 Aug; 45(8):740.
    View in: PubMed
    Score: 0.395
  4. Painful tongue ulcerations in patients with bisphosphonate-associated osteonecrosis of the jaws. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008 Jun; 105(6):e1-4.
    View in: PubMed
    Score: 0.378
  5. Clinical evaluation of oral chronic graft-versus-host disease. Biol Blood Marrow Transplant. 2008 Jan; 14(1):110-5.
    View in: PubMed
    Score: 0.371
  6. Images in clinical medicine. Bisphosphonate-associated osteonecrosis of the jaw. N Engl J Med. 2006 Nov 30; 355(22):2348.
    View in: PubMed
    Score: 0.344
  7. Dyskeratosis congenita vs. chronic graft versus host disease: report of a case and a review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004 Nov; 98(5):566-71.
    View in: PubMed
    Score: 0.298
  8. Oral mucosal pigmentation secondary to minocycline therapy: report of two cases and a review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004 Jun; 97(6):718-25.
    View in: PubMed
    Score: 0.289
  9. Case 33-2021: A 68-Year-Old Man with Painful Mouth Ulcers. N Engl J Med. 2021 Oct 28; 385(18):1700-1710.
    View in: PubMed
    Score: 0.242
  10. Oral manifestations of immune-related adverse events in cancer patients treated with immune checkpoint inhibitors. Oral Dis. 2022 Jan; 28(1):9-22.
    View in: PubMed
    Score: 0.238
  11. Immunohistopathological characterization and the impact of topical immunomodulatory therapy in oral chronic graft-versus-host disease: A pilot study. Oral Dis. 2018 May; 24(4):580-590.
    View in: PubMed
    Score: 0.188
  12. Oral health status and risk of bacteremia following allogeneic hematopoietic cell transplantation. Oral Surg Oral Med Oral Pathol Oral Radiol. 2017 Sep; 124(3):253-260.
    View in: PubMed
    Score: 0.179
  13. Osteonecrosis of the jaw associated with ziv-aflibercept. J Gastrointest Oncol. 2016 Dec; 7(6):E81-E87.
    View in: PubMed
    Score: 0.172
  14. Utilization of Compounded Medications in an Oral Medicine Practice. Int J Pharm Compd. 2016 Mar-Apr; 20(2):155-8.
    View in: PubMed
    Score: 0.163
  15. Oral Medicine referrals at a hospital-based practice in the United States. Oral Surg Oral Med Oral Pathol Oral Radiol. 2015 Apr; 119(4):423-9.
    View in: PubMed
    Score: 0.151
  16. Mammalian target of rapamycin inhibitor-associated stomatitis in hematopoietic stem cell transplantation patients receiving sirolimus prophylaxis for graft-versus-host disease. Biol Blood Marrow Transplant. 2015 Mar; 21(3):503-8.
    View in: PubMed
    Score: 0.150
  17. Characterization of oral involvement in acute graft-versus-host disease. Biol Blood Marrow Transplant. 2014 Nov; 20(11):1717-21.
    View in: PubMed
    Score: 0.145
  18. Oral graft-versus-host disease. Dent Clin North Am. 2014 Apr; 58(2):351-68.
    View in: PubMed
    Score: 0.143
  19. Cost analysis of dental services needed before hematopoietic cell transplantation. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014 Jan; 117(1):59-66.
    View in: PubMed
    Score: 0.141
  20. Characterization and management of exfoliative cheilitis: a single-center experience. Oral Surg Oral Med Oral Pathol Oral Radiol. 2013 Dec; 116(6):e485-9.
    View in: PubMed
    Score: 0.140
  21. Conservative management of bisphosphonate-related osteonecrosis of the jaws: staging and treatment outcomes. Oral Oncol. 2013 Sep; 49(9):977-983.
    View in: PubMed
    Score: 0.136
  22. Extensive dental caries in patients with oral chronic graft-versus-host disease. Biol Blood Marrow Transplant. 2012 Oct; 18(10):1573-9.
    View in: PubMed
    Score: 0.125
  23. Oral verruciform xanthoma associated with chronic graft-versus-host disease: a report of five cases and a review of the literature. Head Neck Pathol. 2011 Jun; 5(2):193-8.
    View in: PubMed
    Score: 0.115
  24. Case report: osteonecrosis of the mandible after laryngoscopy and endotracheal tube placement. Anesth Analg. 2010 Aug; 111(2):437-41.
    View in: PubMed
    Score: 0.109
  25. Oral chronic graft-versus-host disease scoring using the NIH consensus criteria. Biol Blood Marrow Transplant. 2010 Jan; 16(1):108-14.
    View in: PubMed
    Score: 0.104
  26. Sinus tracts--an early sign of bisphosphonate-associated osteonecrosis of the jaws? J Oral Maxillofac Surg. 2009 Mar; 67(3):593-601.
    View in: PubMed
    Score: 0.100
  27. Trigeminal trophic syndrome with features of oral CMV disease. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008 Sep; 106(3):e15-8.
    View in: PubMed
    Score: 0.096
  28. Calcineurin inhibitor-associated oral inflammatory polyps after transplantation. J Oral Pathol Med. 2007 Oct; 36(9):570-4.
    View in: PubMed
    Score: 0.091
  29. Oral chronic graft-versus-host disease in pediatric patients after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2005 Sep; 11(9):721-31.
    View in: PubMed
    Score: 0.079
  30. Scoring system for monitoring oral lichenoid lesions: a preliminary study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005 Jun; 99(6):696-703.
    View in: PubMed
    Score: 0.077
  31. Oral myeloid sarcoma as an uncommon manifestation of acute myeloid leukemia: A case series and review of the literature. J Am Dent Assoc. 2021 May; 152(5):393-400.e8.
    View in: PubMed
    Score: 0.058
  32. Corrigendum to "Intralesional Triamcinolone Acetonide Therapy for Inflammatory Oral Ulcers". Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, Volume 128, Issue 5, 485 - 490. Oral Surg Oral Med Oral Pathol Oral Radiol. 2020 05; 129(5):549.
    View in: PubMed
    Score: 0.054
  33. Oral immune-related adverse events associated with PD-1 inhibitor therapy: A case series. Oral Dis. 2020 Mar; 26(2):325-333.
    View in: PubMed
    Score: 0.053
  34. Burning mouth syndrome: a diagnostic challenge. Oral Surg Oral Med Oral Pathol Oral Radiol. 2020 Feb; 129(2):120-124.
    View in: PubMed
    Score: 0.052
  35. Intralesional triamcinolone acetonide therapy for inflammatory oral ulcers. Oral Surg Oral Med Oral Pathol Oral Radiol. 2019 Nov; 128(5):485-490.
    View in: PubMed
    Score: 0.052
  36. Evaluation of a community-based dental screening program prior to radiotherapy for head and neck cancer: a single-center experience. Support Care Cancer. 2019 Sep; 27(9):3331-3336.
    View in: PubMed
    Score: 0.050
  37. Integrated genomic characterization of oral carcinomas in post-hematopoietic stem cell transplantation survivors. Oral Oncol. 2018 06; 81:1-9.
    View in: PubMed
    Score: 0.047
  38. The Use of Hyperbaric Oxygen for the Prevention and Management of Osteoradionecrosis of the Jaw: A Dana-Farber/Brigham and Women's Cancer Center Multidisciplinary Guideline. Oncologist. 2017 11; 22(11):1413.
    View in: PubMed
    Score: 0.046
  39. Topical Clonazepam Solution for the Management of Burning Mouth Syndrome: A Retrospective Study. J Oral Facial Pain Headache. 2017 Summer; 31(3):257-263.
    View in: PubMed
    Score: 0.045
  40. Safety and tolerability of topical clonazepam solution for management of oral dysesthesia. Oral Surg Oral Med Oral Pathol Oral Radiol. 2017 Aug; 124(2):146-151.
    View in: PubMed
    Score: 0.044
  41. The Use of Hyperbaric Oxygen for the Prevention and Management of Osteoradionecrosis of the Jaw: A Dana-Farber/Brigham and Women's Cancer Center Multidisciplinary Guideline. Oncologist. 2017 03; 22(3):343-350.
    View in: PubMed
    Score: 0.044
  42. Quality of life implications of bisphosphonate-associated osteonecrosis of the jaw. Oncologist. 2011; 16(1):121-32.
    View in: PubMed
    Score: 0.029
  43. AAOMP case challenge: a nodule of the palate. J Contemp Dent Pract. 2008 May 01; 9(4):124-8.
    View in: PubMed
    Score: 0.024
  44. Clinical, radiographic, and biochemical characterization of multiple myeloma patients with osteonecrosis of the jaw. Clin Cancer Res. 2008 Apr 15; 14(8):2387-95.
    View in: PubMed
    Score: 0.024
  45. Rituximab for steroid-refractory chronic graft-versus-host disease. Blood. 2006 Jul 15; 108(2):756-62.
    View in: PubMed
    Score: 0.020
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.